Join us in Las Vegas for this

Midday Symposium Conducted at the 2022 ASHP Midyear Clinical Meeting & Exhibition!

 Adding It All Up:

Cost-effectiveness Considerations for Ready-to-Administer IV Push Products

Patient safety is always a primary concern, but outside factors, including additional stress caused by COVID-19 and diversion of controlled substances, have added challenges to IV medication processes. Complicating matters is that the true costs of safety of IV drug delivery systems are unknown and extend well beyond the cost of acquiring these technologies. This educational activity will review the peer-reviewed literature relating to the selection and use of manufacturer-prepared ready-to-administer (RTA) and traditional vial products on the basis of safety, waste, and workforce considerations. The importance of incorporating cost-effectiveness data into purchasing decisions will also be described as they relate to improving care, reducing diversion, enhancing patient safety, and maximizing resources.

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT

Come early! Seating is limited and provided on a first-come, first-served basis.

Symposium Location: Islander Ballroom F, Lower Level, Mandalay Bay North Convention Center

Can't make it to Vegas? Tune into the Live Webinar Broadcast:

Tuesday, Dec. 6

11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

 Registration is required for the webinar. 

Featuring...

John B. Hertig

PharmD, MS, CPPS, FASHP, FFIP

Activity Chair

Associate Professor
Butler University College of Pharmacy and Health Sciences
Indianapolis, Indiana

Jeffrey S. Vender

MD

Clinical Professor Anesthesia
University of Chicago
Chicago, Illinois

Ryan Haumschild

PharmD, MS, MBA

Director of Pharmaceutical Services
Emory Healthcare
Atlanta, Georgia

Target Audience

This activity was planned to meet the educational needs of pharmacists, especially chief pharmacy officers, pharmacy leaders and administrators, medication safety and compliance officers, and procurement managers who work in hospitals and health systems.

Learning Objectives

• Evaluate peer-reviewed literature that relates to the selection and use of manufacturer-prepared ready to administer (RTA) and traditional IV vial products.
• Explain the importance of incorporating cost-effectiveness data in the selection of IV push products.
• Identify the impact of integrating and adopting manufacturer-prepared RTA syringes within a health-system.

Agenda

11:30 a.m. - Welcome and Introductions

John B. Hertig, PharmD, MS, CPPS, FASHP

11:35 a.m. - Making the Case for RTA IV Push Products: Assessing Key Variables

Jeffery S. Vender, MD, MCCM, FCCP

11:50 a.m. - A Holistic Approach to the Selection of IV Push Products

John B. Hertig, PharmD, MS, CPPS, FASHP

12:20 p.m. - A Case-based Approach to Integrating and Adopting Manufacturer-prepared RTA Syringes

Ryan Haumschild, PharmD, MS, MBA

12:50 p.m. - Faculty Discussion and Questions and Answers

John B. Hertig, PharmD, MS, CPPS, FASHP

Jeffery S. Vender, MD, MCCM, FCCP

Ryan Haumschild, PharmD, MS, MBA

Accredited for CPE

ACPE #:0204-0000-22-427-L04-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

Activity Fee: No charge 

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Provided by ASHP.
Supported by an educational grant from Fresenius Kabi USA, LLC.
For questions and assistance to participate, contact us.